Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rubella”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05758532
What this trial is testing

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Who this might be right for
Respiratory Tract InfectionsInfectionsAllergy+1 more
Laure Pittet, MD-PhD 500
Post-approval studies (Phase 4)Study completedNCT04111432
What this trial is testing

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 372
Post-approval studies (Phase 4)Study completedNCT00388440
What this trial is testing

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Who this might be right for
RubellaMumpsMeasles
GlaxoSmithKline 150
Large-scale testing (Phase 3)Study completedNCT04183114
What this trial is testing

Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

Who this might be right for
Congenital Rubella InfectionMeasles
PT Bio Farma 540
Post-approval studies (Phase 4)Study completedNCT00312858
What this trial is testing

Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)

Who this might be right for
Hepatitis A Virus
Merck Sharp & Dohme LLC 653
Not applicableStudy completedNCT04428359
What this trial is testing

A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts

Who this might be right for
Verruca Viral
B.P. Koirala Institute of Health Sciences 66
Not applicableStudy completedNCT00962819
What this trial is testing

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Who this might be right for
MeaslesMumpsRubella
Sri Edupuganti, MD MPH 74
Large-scale testing (Phase 3)Looking for participantsNCT07406360
What this trial is testing

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

Who this might be right for
MeaslesMeasles-Mumps-Rubella+Chickenpox Vaccine
GlaxoSmithKline 1,209
Not applicableStudy completedNCT01369394
What this trial is testing

Making Decisions About the Measles-Mumps-Rubella Vaccine

Who this might be right for
MeaslesMumpsRubella+1 more
University of Michigan 79
Large-scale testing (Phase 3)Study completedNCT00092430
What this trial is testing

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,200
Testing effectiveness (Phase 2)Study completedNCT00861744
What this trial is testing

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Who this might be right for
RubellaMumpsMeasles+1 more
GlaxoSmithKline 1,259
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT00969436
What this trial is testing

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Who this might be right for
VaricellaRubellaMumps+1 more
GlaxoSmithKline 450
Post-approval studies (Phase 4)Study completedNCT00126997
What this trial is testing

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline 1,439
Testing effectiveness (Phase 2)Study completedNCT00109278
What this trial is testing

A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)

Who this might be right for
Measles
Merck Sharp & Dohme LLC 1,100
Very early researchStudy completedNCT02687763
What this trial is testing

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

Who this might be right for
RENAL INSUFFICIENCY, CHRONICLIVER FAILURE, ACUTEHEART DISEASE
Medical University of South Carolina 5
Large-scale testing (Phase 3)Study completedNCT02699099
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 699
Testing effectiveness (Phase 2)Study completedNCT00986232
What this trial is testing

ProQuad Dose Selection Study (V221-011)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,551
Large-scale testing (Phase 3)Not Yet RecruitingNCT07742644
What this trial is testing

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age

Who this might be right for
MeaslesMumpsRubella+2 more
GlaxoSmithKline 1,860
Not applicableStudy completedNCT01544764
What this trial is testing

Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina

Who this might be right for
Adolescent Health ServicesImmunization
University of North Carolina, Chapel Hill 91
Next Page